Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Global Inc Regulatory News (CMPI)

Share Price Information for Ct Global Inc (CMPI)

Share Price is delayed by 15 minutes
Get Live Data
132.50    0.00 (0.00%)
Bid:
130.00
Ask:
135.00
Spread: 5.00 (3.846%)
Market Cap: £125.89m
CMPI Live PriceLast checked at - London Stock Exchange

Intraday Ct Global Inc Share Chart

Conversion of Shares

5 Nov 2025 11:10

RNS Number : 3119G
CT Global Managed Portfolio - CMPI
05 November 2025
 

To: RNS

From: CT Global Managed Portfolio Trust PLC

Date: 5 November 2025

LEI: 213800ZA6TW45NM9YY31

 

 

Conversion of shares

 

Shareholders of CT Global Managed Portfolio Trust PLC (the "Company") have the opportunity to convert their Income shares into Growth shares or their Growth shares into Income shares annually, subject to minimum conversion thresholds.

 

The Company announces that valid conversion notices were received in respect of the following shares (the "Converting Shares"):

 

- 85,315 Growth shares; and

- 248,593 Income shares

 

In accordance with the Company's articles of association, the Converting Shares will be converted into the other share class by reference to the ratio of the relative underlying net asset values of the Growth shares and Income shares as at close of business on 29 October 2025.

 

The conversion ratios were:

 

- for every Converting Share which is a Growth share, holders are entitled to 2.464629 Income shares and

- for every Converting Share which is an Income share, holders are entitled to 0.405741 Growth shares.

 

Accordingly, with effect from 8.00 a.m. on 6 November 2025 the above Converting Shares will be converted into:

 

- 210,269 Income shares; and

- 100,864 Growth shares

 

(the "Resulting Shares").

 

Shareholders' entitlements on conversion are rounded down to the nearest whole number of share. The Resulting Shares will rank pari passu with the existing shares of the relevant class.

 

The Resulting shares have been allotted conditional only to admission to the Official List of the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange.

Applications have been made for the Resulting Shares to be admitted to the Official List of the Financial Conduct Authority and to the London Stock Exchange for the Resulting Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealings will commence in such shares at 8.00 a.m. on 6 November 2025.

It is anticipated that certificates in respect of the Resulting Shares will be posted by 12 November 2025 and CREST accounts credited on 6 November 2025.

 

Total voting rights

 

Following the conversion, the Company's issued share capital consists of 54,502,194 Income shares and 38,756,710 Growth shares, of which 100,000 Income shares and 5,888,000 Growth shares are held in treasury.

Therefore the total number of shares with voting rights in the Company is 54,402,194 Income shares and 32,868,710 Growth shares. These figures may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Ian Ridge, Columbia Threadneedle Investment Business Limited 0131 573 8316

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CONBABBTMTMMBRA
Date   Source Headline
9th Jan 202612:42 pmRNSNet Asset Value(s)
8th Jan 20261:03 pmRNSNet Asset Value(s)
7th Jan 20264:11 pmRNSIssue of Equity
7th Jan 202612:34 pmRNSNet Asset Value(s)
6th Jan 20264:32 pmRNSIssue of Equity
6th Jan 202612:15 pmRNSNet Asset Value(s)
5th Jan 202612:58 pmRNSNet Asset Value(s)
2nd Jan 20263:47 pmRNSIssue of Equity
2nd Jan 202612:46 pmRNSNet Asset Value(s)
2nd Jan 202612:33 pmRNSTotal Voting Rights
31st Dec 20251:34 pmRNSChair of the Marketing Committee
31st Dec 20251:34 pmRNSChair of the Marketing Committee
31st Dec 202512:56 pmRNSNet Asset Value(s)
30th Dec 20253:04 pmRNSIssue of Equity
30th Dec 20253:04 pmRNSIssue of Equity
30th Dec 202512:36 pmRNSNet Asset Value(s)
29th Dec 20254:39 pmRNSIssue of Equity
29th Dec 20254:39 pmRNSIssue of Equity
29th Dec 20251:34 pmRNSNet Asset Value(s)
24th Dec 202512:08 pmRNSNet Asset Value(s)
23rd Dec 20251:27 pmRNSIssue of Equity
23rd Dec 20251:27 pmRNSIssue of Equity
23rd Dec 202512:46 pmRNSNet Asset Value(s)
22nd Dec 20251:00 pmRNSNet Asset Value(s)
19th Dec 20252:53 pmRNSIssue of Equity
19th Dec 20252:53 pmRNSIssue of Equity
19th Dec 202512:49 pmRNSNet Asset Value(s)
19th Dec 20258:56 amRNSPortfolio Update
19th Dec 20258:56 amRNSPortfolio Update
18th Dec 20253:42 pmRNSIssue of Equity
18th Dec 20253:42 pmRNSIssue of Equity
18th Dec 202512:38 pmRNSNet Asset Value(s)
17th Dec 20254:05 pmRNSIssue of Equity
17th Dec 202512:32 pmRNSNet Asset Value(s)
16th Dec 202512:49 pmRNSNet Asset Value(s)
15th Dec 20254:30 pmRNSIssue of Equity
15th Dec 202512:42 pmRNSNet Asset Value(s)
12th Dec 20253:00 pmRNSIssue of Equity
12th Dec 202512:54 pmRNSNet Asset Value(s)
11th Dec 202512:41 pmRNSNet Asset Value(s)
10th Dec 202512:34 pmRNSNet Asset Value(s)
9th Dec 20253:38 pmRNSIssue of Equity
9th Dec 202512:41 pmRNSNet Asset Value(s)
9th Dec 202510:25 amRNSBlock Listing Application
8th Dec 202512:39 pmRNSNet Asset Value(s)
5th Dec 20251:00 pmRNSNet Asset Value(s)
4th Dec 20254:07 pmRNSPortfolio Update
4th Dec 202512:30 pmRNSNet Asset Value(s)
4th Dec 202510:16 amRNSDividend Declaration
3rd Dec 20255:05 pmRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.